Cargando…

The determinants of patient care manager role and the implementation of COVID-19 clinical pathway: a cross-sectional study

OBJECTIVE: This study aims to determine the factors associated with patient care manager role and the implementation of the clinical pathway among nurses in private hospitals. METHODS: This study was conducted from January–July 2021 using the cross-sectional approach. The sample consisted of 168 nur...

Descripción completa

Detalles Bibliográficos
Autores principales: Aziz Alimul Hidayat, Abdul, Chen, Wen-Ling, Nor, Rahimah Mohd, Uliyah, Musrifatul, Badriyah, Fatin Lailatul, Ubudiyah, Masunatul
Formato: Online Artículo Texto
Lenguaje:English
Publicado: PeerJ Inc. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9332306/
https://www.ncbi.nlm.nih.gov/pubmed/35910779
http://dx.doi.org/10.7717/peerj.13764
Descripción
Sumario:OBJECTIVE: This study aims to determine the factors associated with patient care manager role and the implementation of the clinical pathway among nurses in private hospitals. METHODS: This study was conducted from January–July 2021 using the cross-sectional approach. The sample consisted of 168 nurses working in a private hospital in Surabaya City, East Java, Indonesia. Meanwhile, the data were collected using the Patient Care Manager Role Scale (PCMRS) and analyzed by multiple logistic regression to find the correlation between the variables. RESULTS: A higher percentage of nurses namely 64.3% had compliance in COVID-19 clinical pathways with an average PCMRS score of 27.81 ± 2.43. Nurses with a high-level patient care manager role level had a significant compliance risk with odds ratio [OR] 440.137, 95% confidence interval [CI] [51.850–3736.184], and p-value = 0.000 compared to those with a low role. CONCLUSION: The role of patient care manager and compliance with COVID-19 clinical pathways correlated significantly. Based on the results, several actions are needed for the early identification of patient service managers’ roles to ensure compliance with COVID-19 clinical pathways and reduce the number of cases in Indonesia.